01564oam 2200385Ia 450 991069899140332120090611160429.0(CKB)5470000002397958(OCoLC)388281444(EXLCZ)99547000000239795820090611d2006 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry and FDA staff[electronic resource] early development considerations for innovative combination productsRockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Office of the Commissioner, Office of Combination Products,[2006]13 pages digital, PDF fileTitle from PDF title page (viewed on June 11, 2009).Guidance for industry and FDA staff Medical instruments and apparatusGovernment policyUnited StatesDrug developmentGovernment policyUnited StatesBiological productsGovernment policyUnited StatesMedical instruments and apparatusGovernment policyDrug developmentGovernment policyBiological productsGovernment policyUnited States.Food and Drug Administration.Office of Combination Products.GPOGPOGPOBOOK9910698991403321Guidance for industry and FDA staff3451983UNINA